Article Details
Retrieved on: 2021-06-21 12:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotech firm Theravance Biopharma said that a trial of its drug nezulcitinib in hospitalized patients with acute lung injury caused by Covid-19 had ...
Article found on: www.barrons.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here